Todd Chermak is Abbott's head of innovation and development for emerging markets. "Drug Makers Find 'Branded Generics' Are a Source for Growth" at 8:10 ET, incorrectly spelled his surname as Chermark in the 24th paragraph. (Oct. 23)

 

(END) Dow Jones Newswires

October 23, 2017 11:11 ET (15:11 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.
Novartis (NYSE:NVS)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Novartis Charts.
Novartis (NYSE:NVS)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Novartis Charts.